Waystone Advisors’s Amgen AMGN Stock Holding History

Waystone Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Sell	1,113 -8	-0.7%	-$2.74K	0.3%	73
2026 Q1	$394K	Sell	1,121 -42	-4%	-$15K	0.35%	67
2025 Q4	$381K	Buy	+1,163	New	+$369K	0.33%	70

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Waystone Advisors's AMGN Position: Q2 2026 in Review

Waystone Advisors reduced its Amgen (AMGN) stake by 0.71% in Q2 2026, selling an estimated $2.74K and leaving 1,113 shares worth $403K. The position accounts for 0.3% of the portfolio, ranked #73.

Waystone Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Waystone Advisors held 1,113 shares of Amgen worth $403K as of Q2 2026.
Waystone Advisors sold 8 Amgen shares in Q2 2026, an estimated $2.74K.
Amgen made up 0.3% of Waystone Advisors's portfolio in Q2 2026, its #73 holding.
Waystone Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Waystone Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.